Neuroprotective mechanisms of oxygen and ethanol: a potential combination therapy in stroke

Sweena Parmar, Shannon Moore-Langston, Vance Fredrickson

  • 1Department of Neurological Surgery, Wayne State University School of Medicine, 550 E Canfield, Detroit, MI 48201, USA. yding@med.wayne.edu.

Insights

This study explores combining normobaric oxygen (NBO) and ethanol for stroke treatment. This combination therapy may offer better neuroprotection against ischemic injury than single agents by targeting multiple pathways.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Emergency Medicine

Background:

  • Stroke research faces challenges with neuroprotective agents failing in clinical trials.
  • Ischemic stroke involves multiple injury pathways, suggesting combination therapy may be more effective.
  • Existing single-agent neuroprotective strategies have limited clinical success.

Purpose of the Study:

  • To review the potential of combining normobaric oxygen (NBO) and ethanol as a neuroprotective stroke therapy.
  • To evaluate the historical use, mechanisms, and clinical trial data for NBO and ethanol in stroke.
  • To establish the rationale for using NBO and ethanol in combination for stroke treatment.

Main Methods:

  • Literature review of normobaric oxygen (NBO) therapy in stroke.
  • Literature review of ethanol therapy in stroke.
  • Analysis of existing clinical trial data for NBO and ethanol.
  • Synthesis of evidence supporting combination therapy.

Main Results:

  • Normobaric oxygen (NBO) therapy enhances tissue oxygenation, reducing hypoxic injury and necrosis post-stroke.
  • Low to moderate ethanol levels are associated with reduced stroke risk and improved post-ischemic outcomes.
  • Evidence suggests NBO and ethanol target distinct but complementary pathways in ischemic stroke.

Conclusions:

  • Combination therapy with normobaric oxygen (NBO) and ethanol presents a promising neuroprotective strategy for stroke.
  • This combined approach may overcome limitations of single-agent therapies by addressing multiple injury mechanisms.
  • Further investigation into the clinical application of NBO and ethanol combination therapy is warranted.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
2
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
3
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
3